Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 5 , Pages 410-411 , September 2006

11C-Acetate positron emission tomography for occult prostate cancer

  • Michael Froehner, M.D.

      Affiliations

    • Department of Urology, University Hospital, Technical University of Dresden, Dresden, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-351-4582447; fax: +49-351-4584333.
  • ,
  • Bettina Beuthien-Baumann, M.D.

      Affiliations

    • Department of Nuclear Medicine and PET Center Rossendorf, University Hospital, Technical University of Dresden, Dresden, Germany
  • ,
  • Manfred P. Wirth, M.D.

      Affiliations

    • Department of Urology, University Hospital, Technical University of Dresden, Dresden, Germany

Received 8 August 2005 ,Revised 4 October 2005 ,Accepted 5 October 2005.

References 

  1. Brassell SA , Rosner IL , McLeod DG . Update on magnetic resonance imaging, ProstaScint, and novel imaging in prostate cancer . Curr Opin Urol . 2005;15:163–166
  2. Matthies A , Ezziddin S , Ulrich EM , et al.   Imaging of prostate cancer metastases with 18F-fluoroacetate using PET/CT . Eur J Nucl Med Mol Imaging . 2004;31:797
  3. Hain SF . Positron emission tomography in uro-oncology . Cancer Imaging . 2005;5:1–7
  4. Malmström PU . Lymph node staging in prostatic carcinoma revisited . Acta Oncol . 2005;44:593–598
  5. Oyama N , Miller TR , Dehdashti F , et al.   11C-acetate PET imaging of prostate cancer: Detection of recurrent disease at PSA relapse . J Nucl Med . 2003;44:549–555
  6. Grosu A , Piert M , Weber WA , et al.   Positron emission tomography for radiation treatment planning . Strahlenther Onkol . 2005;181:483–499
  7. Hersh MR , Knapp EL , Choi J . Newer imaging modalities to assess tumor in the prostate . Cancer Control . 2004;11:353–357

PII: S1078-1439(05)00259-0

doi: 10.1016/j.urolonc.2005.10.003

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 5 , Pages 410-411 , September 2006